These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

572 related items for PubMed ID: 11527118

  • 1. Beta-blocking agents and positive inotropic agents in the therapy of chronic heart failure.
    Erdmann E, Schwinger R, Böhm M.
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S138-44. PubMed ID: 11527118
    [Abstract] [Full Text] [Related]

  • 2. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M.
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [Abstract] [Full Text] [Related]

  • 3. Receptor systems affecting force of contraction in the human heart and their alterations in chronic heart failure.
    Brodde OE, Hillemann S, Kunde K, Vogelsang M, Zerkowski HR.
    J Heart Lung Transplant; 1992 Nov; 11(4 Pt 2):S164-74. PubMed ID: 1355362
    [Abstract] [Full Text] [Related]

  • 4. The role of cardiac beta1- and beta2-adrenoceptor stimulation in heart failure.
    Khamssi M, Brodde OE.
    J Cardiovasc Pharmacol; 1990 Nov; 16 Suppl 5():S133-7. PubMed ID: 11527117
    [Abstract] [Full Text] [Related]

  • 5. [Importance of beta 2-adrenergic receptors in heart failure].
    Brodde OE, Daul A, Michel MC, Zerkowski HR.
    Z Kardiol; 1992 Nov; 81 Suppl 4():71-8. PubMed ID: 1363262
    [Abstract] [Full Text] [Related]

  • 6. Ouabain treatment is associated with upregulation of phosphatase inhibitor-1 and Na+/Ca(2+)-exchanger and beta-adrenergic sensitization in rat hearts.
    El-Armouche A, Jaeckel E, Boheler KR, Boknik P, Hertle B, Neumann J, Eschenhagen T.
    Biochem Biophys Res Commun; 2004 May 21; 318(1):219-26. PubMed ID: 15110776
    [Abstract] [Full Text] [Related]

  • 7. Increased contribution of alpha 1- vs. beta-adrenoceptor-mediated inotropic response in rats with congestive heart failure.
    Sjaastad I, Schiander I, Sjetnan A, Qvigstad E, Bøkenes J, Sandnes D, Osnes JB, Sejersted OM, Skomedal T.
    Acta Physiol Scand; 2003 Apr 21; 177(4):449-58. PubMed ID: 12648162
    [Abstract] [Full Text] [Related]

  • 8. [Beta-adrenergic receptors of the normal heart and in heart failure].
    Krasnikov TL, Gabrusenko SA.
    Usp Fiziol Nauk; 2000 Apr 21; 31(2):35-50. PubMed ID: 10822833
    [Abstract] [Full Text] [Related]

  • 9. [Adrenergic beta receptors and guanine nucleotide binding proteins (G-proteins) of the failing human heart].
    Böhm M, Schwinger RH, Erdmann E.
    Z Kardiol; 1992 Apr 21; 81 Suppl 4():23-31. PubMed ID: 1337808
    [Abstract] [Full Text] [Related]

  • 10. Cardiac inotropic as well as coronary and pulmonary artery actions of epinine in human isolated tissues.
    Schwinger RH, Böhm M, Schulz C, Schmidt U, Schmidt U, Schmid B, Dienemann H, Reichart B, Erdmann E.
    J Pharmacol Exp Ther; 1993 Apr 21; 265(1):346-57. PubMed ID: 8386240
    [Abstract] [Full Text] [Related]

  • 11. Comparison between alpha-1 adrenoceptor-mediated and beta adrenoceptor-mediated inotropic components elicited by norepinephrine in failing human ventricular muscle.
    Skomedal T, Borthne K, Aass H, Geiran O, Osnes JB.
    J Pharmacol Exp Ther; 1997 Feb 21; 280(2):721-9. PubMed ID: 9023284
    [Abstract] [Full Text] [Related]

  • 12. [Cardiac beta receptors--experimental aspects].
    Kaumann AJ.
    Z Kardiol; 1983 Feb 21; 72(2):63-82. PubMed ID: 6133398
    [Abstract] [Full Text] [Related]

  • 13. [Positive inotropic substances in therapy of heart failure: digitalis, catecholamines, phosphodiesterase inhibitors].
    Stefenelli T.
    Acta Med Austriaca; 1991 Feb 21; 18(4):81-5. PubMed ID: 1763582
    [Abstract] [Full Text] [Related]

  • 14. A novel approach to the development of positive inotropic agents for chronic heart failure.
    Packer M.
    J Cardiovasc Pharmacol; 1995 Feb 21; 26 Suppl 1():S52-6. PubMed ID: 8907131
    [Abstract] [Full Text] [Related]

  • 15. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
    Molenaar P, Chen L, Semmler AB, Parsonage WA, Kaumann AJ.
    Clin Exp Pharmacol Physiol; 2007 Oct 21; 34(10):1020-8. PubMed ID: 17714089
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure.
    Steinfath M, Danielsen W, von der Leyen H, Mende U, Meyer W, Neumann J, Nose M, Reich T, Schmitz W, Scholz H.
    Br J Pharmacol; 1992 Feb 21; 105(2):463-9. PubMed ID: 1348446
    [Abstract] [Full Text] [Related]

  • 18. Calcitonin gene-related peptide in vivo positive inotropy is attributable to regional sympatho-stimulation and is blunted in congestive heart failure.
    Katori T, Hoover DB, Ardell JL, Helm RH, Belardi DF, Tocchetti CG, Forfia PR, Kass DA, Paolocci N.
    Circ Res; 2005 Feb 04; 96(2):234-43. PubMed ID: 15591228
    [Abstract] [Full Text] [Related]

  • 19. Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium.
    Bristow MR, Hershberger RE, Port JD, Gilbert EM, Sandoval A, Rasmussen R, Cates AE, Feldman AM.
    Circulation; 1990 Aug 04; 82(2 Suppl):I12-25. PubMed ID: 2164894
    [Abstract] [Full Text] [Related]

  • 20. [Positive inotropic substances--therapeutic perspectives].
    Erdmann E, Böhm M.
    Z Kardiol; 1991 Aug 04; 80 Suppl 8():57-62. PubMed ID: 1796636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.